Table 5.
Haplotype analysis in patients with CAD and control subjects.
Haplotype | SNP2 | SNP4 | Control, n (%) (n = 1082) | CAD, n (%) (n = 950) | OR[95%CI] | P value |
---|---|---|---|---|---|---|
H1 | C | A | 1488.21 (0.69) | 1354.26 (0.71) | 1.13 [0.99–1.29] | 0.082 |
H2 | C | G | 13.79 (0.01) | 23.74 (0.01) | 1.97 [1.01–3.84] | 0.042* |
H3 | T | A | 553.79 (0.26) | 473.74 (0.25) | 0.97 [0.84–1.11] | 0.630 |
H4 | T | G | 108.21 (0.05) | 48.26 (0.03) | 0.49 [0.35–0.70] | < 0.001* |
SNP2: rs2483205; SNP4: rs562556. *: p < 0.05.